Methodology & Coverage

How to Use This Report

NIH-funded research is a leading indicator of commercial opportunity. Public funding typically precedes private activity by 3-7 years, so the projects, PIs, IP filings, and clinical programs surfaced here are early signals of which technologies will produce the next wave of companies, partnerships, and deals in this space.

The intelligence in this report comes primarily from our semantic analysis across the linked data, not from any single source. NIH RePORTER, ClinicalTrials.gov, USPTO, and PubMed are all publicly searchable - anyone can look up individual records. Our value is in:

• Identifying conceptually-related projects via AI semantic search rather than brittle keyword matching
• Cross-linking each project to its associated patents, clinical trials, and publications
• Synthesizing across the analyzed sample to surface patterns no single record reveals - competitive topology, IP concentration, field maturity, and momentum signals

The Market Context section adds external color sourced via live web search. It is supplementary to the core analysis above.

What This Report Does Not Cover

A short, upfront note on the boundaries of this analysis. We surface this so you can read everything below with the right calibration.

• Companies are in this data - non-NIH-funded internal R&D is not. SBIR/STTR grantees, academic-industry partnerships, and commercial entities receiving NIH funding do appear and carry real commercial weight. What's invisible is privately-funded R&D inside companies that doesn't intersect with an NIH grant.
• International activity is largely outside the sample. NIH RePORTER captures US grantees and their direct collaborators. Major work in Europe, China, Japan, and elsewhere is not reflected unless tied to a US-funded project.
• Linked outputs require an NIH grant acknowledgment. A clinical trial, patent, or publication only appears here if it was filed with an NIH project number. Industry-led trials, non-USPTO patents, and papers without NIH funding acks are missing - even when central to the field.
• Recent quarter activity may be incomplete. NIH RePORTER updates with a lag of several weeks; some current-fiscal-year awards may not yet be visible.
• Umbrella institutional grants are not credited to topic funding. Some trials and patents in this report are hosted under broad institutional support awards (P30 cancer centers, CTSA hubs, training grants) whose parent grant covers many programs beyond this topic. Those records appear in the trials and patents sections, but the host grants' dollars are deliberately excluded from Total Committed Funding to keep the headline number topically attributable. Real topic activity at those institutions is therefore likely higher than the funding figures alone suggest.
• Market context is web-sourced, not exhaustive - see the Sources subsection in Market Context for what was retrieved.
• Project categorization is automated. A single primary category is assigned per project by AI classification, with confidence scores. Some boundary cases (especially infrastructure vs. biotools) may be misassigned.

This is depth-over-breadth analysis - high signal on what NIH funds and produces, including its commercial recipients. For pure private-market intelligence (funding rounds, M&A, internal pipelines), supplement with PitchBook, CB Insights, or industry analyst reports.

About This Report

Methodology

This report analyzes a curated subset of NIH-funded research projects most relevant to brain organoid electrophysiology. Projects were identified using semantic search (AI-based conceptual matching) and filtered by match quality.

Search Interpretation Used: Standard - "brain organoid electrophysiology including neural organoids and patch clamp recording"

Note on Funding Figures: Per-project funding amounts shown in this report are the sum of award totals across all budget periods for each project (not just the most recent year). Funding-by-year figures show actual spend per fiscal year drawn from the underlying NIH RePORTER budget-period rows, so a multi-year project contributes to each year it received funding. The current NIH fiscal year (Oct 1 - Sep 30) is partial when this report is generated; that year is labeled "(YTD)" in tables and charts and should not be compared directly to fully-reported prior years.

Note on Funding Attribution: Clinical trials are surfaced through two paths - direct linkage to topically-relevant projects, and semantic similarity between the trial's own title and the topic (using the same vector-embedding mechanism that powers project search, gated by a dedicated trial-inclusion threshold). The second path catches trials that sit under broad institutional umbrella awards (e.g., P30 cancer center support grants, CTSA hubs) whose underlying parent grant covers many unrelated programs. Those trials are reported because their titles are clearly about the topic, but their umbrella grants' funding is not rolled into Total Committed Funding - only projects whose own abstracts clear the project-relevance threshold contribute to funding totals. This keeps the headline funding number topically attributable rather than inflated by institutional overhead grants that happen to host one relevant program among many.

Match Quality Tiers:

Sample Composition:

Sample Interpretation:

• All 122 matches are Precise (similarity ≥50%). This is not a tuned threshold - it reflects the topic mapping to a tightly-bounded research area where most relevant NIH grants land above the 50% similarity cutoff. Broader topics with less coherent literature produce mixed Precise + Balanced splits (typically 60/40 to 80/20). Note that "Precise" measures semantic similarity to the query, not perfect topical fit - a project can score above the threshold and still touch adjacent research areas (e.g., a project whose main focus is diagnostic biomarkers but whose abstract mentions sepsis biomarkers as comparator work). Treat this signal as "the field's vocabulary aligns well with our query," not as "every project is a pure topic match."

Linked Data:

Limitations

This analysis focuses on depth over breadth, capturing publicly-funded academic research. It does not include privately-funded industry R&D or international research outside NIH grants.

Data current as of September 22, 2026.